Correlative analysis of overall survival by intrinsic subtype across the MONALEESA-2, -3, and -7 studies - report from SABCS2021

from Medical Digest & Congress Report · host Medical Congress News

Professor Lisa A. Carey speaks about the MONALEESA-2, -3, and -7 trials of ribociclib + endocrine therapy in patients with HR+/HER2− advanced breast cancer. Video: https://congressreport.eu/scientific-contents/interview:correlative-analysis-overall-survival-intrinsic-subtype-across-monaleesa-2-3-and-7-studies

Episode metadata supplied by the publisher feed · Published Dec 16, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Correlative analysis of overall survival by intrinsic subtype across the MONALEESA-2, -3, and -7 studies - report from SABCS2021

0:00 4:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 4 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 16, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!